Abstract:Oridonin, a bioactive diterpenoid isolated from Rabdosia rubescens, has been found to exhibit various anti-tumor effects. In this work, to investigate its pharmacological effects on human colorectal carcinoma HCT-116 and LoVo cells, cell proliferation and apoptosis were respectively evaluated by 3-[4,5-dimethylthiazol-2-yl]-2, 5-diphenyltetrazolium bromide (MTT) assay, annexin V-FITC, and propidium iodide (PI) staining. Western blotting was used to detect the expression levels of Bim, Bax, Bcl-2, cytosolic cytochrome c, procaspase-9, cleaved caspase-9, procaspase-3, and caspase-3 proteins. Caspase-Glo-9 and Caspase-Glo-3 assays were applied to determine caspase-9 and caspase-3 activity. MicroRNA-32 (miR-32) expression level was detected by real-time quantitative reverse transcription-polymerase chain reaction (qRT-PCR). The in vivo anti-tumor effects of oridonin were evaluated using cell lines HCT-116 and LoVo xenograft model. The results indicated that oridonin effectively inhibited cell proliferation and induced apoptosis in HCT-116 and LoVo cells in a concentration-dependent manner. Oridonin treatment upregulated the expression levels of Bim, Bax, cytosolic cytochrome c, cleaved caspase-9 and cleaved caspase-3 proteins, downregulated the expression levels of Bcl-2, procaspase-9 and procaspase-3 proteins, and meanwhile obviously activated caspase-9 and caspase-3 in a dose-dependent manner in HCT-116 and LoVo cells. The results of qRT-PCR demonstrated that oridonin treatment significantly decreased miR-32 expression, and furthermore, suppression of miR-32 expression by miR-32 inhibitors augmented oridonin-mediated inhibitory and apoptotic effects in HCT-116 and LoVo cells. In vivo results indicated that oridonin administration through intraperitoneal injection suppressed tumor growth in nude mice. Therefore, these findings suggest that oridonin maybe is a potential candidate for colorectal cancer treatment.

Oridonin Induced Apoptosis Through Akt and MAPKs Signaling Pathways in Human Osteosarcoma Cells.

Oridonin Inhibits Bxpc-3 Cell Growth Through Cell Apoptosis

Honokiol Induces Apoptosis and Autophagy Via the ROS/ERK1/2 Signaling Pathway in Human Osteosarcoma Cells in Vitro and in Vivo.

Oridonin Exerts Anticancer Effect on Osteosarcoma by Activating PPAR-γ and Inhibiting Nrf2 Pathway.

Oridonin Induces G2/M Arrest and Apoptosis Via Activating ERK-p53 Apoptotic Pathway and Inhibiting PTK-Ras-Raf-JNK Survival Pathway in Murine Fibrosarcoma L929 Cells.

Oridonin Inhibits the Proliferation, Migration and Invasion of Human Osteosarcoma Cells Via Suppression of Matrix Metalloproteinase Expression and STAT3 Signalling Pathway.

Molecular Mecha nism of Oridonin in Inhibiting Proliferation and Inducing Apoptosis of Osteosarcoma Cell MG-63

Oridonin Induces G2/M Cell Cycle Arrest and Apoptosis in Human Oral Squamous Cell Carcinoma.

Oridonin‐induced mitochondria‐dependent apoptosis in esophageal cancer cells by inhibiting PI3K/AKT/mTOR and Ras/Raf pathways

Oridonin-induced A431 cell apoptosis partially through blockage of the Ras/Raf/ERK signal pathway.

Oridonin triggers apoptosis in colorectal carcinoma cells and suppression of microRNA-32 expression augments oridonin-mediated apoptotic effects

Oridonin Inhibits Oral Cancer Growth and PI3K/Akt Signaling Pathway.

Oridonin induces human epidermoid carcinoma A431 cell apoptosis through tyrosine kinase and mitochondrial pathway.

Oridonin Induces Apoptosis in SW1990 Pancreatic Cancer Cells Via P53- and Caspase-Dependent Induction of P38 MAPK

Autophagy Inhibits Reactive Oxygen Species‐mediated Apoptosis Via Activating P38‐nuclear Factor‐kappa B Survival Pathways in Oridonin‐treated Murine Fibrosarcoma L929 Cells

Oridonin-induced Apoptosis in Leukemia K562 Cells and Its Mechanism.

Oridonin Induces Human Melanoma A375-S2 Cell Death Partially Through Inhibiting Insulin-Like Growth Factor 1 Receptor Signaling

Altered Gene Expression Reveals Molecular Mechanisms Underlying Oridonin-Induced Apoptosis of Multiple Myeloma LP-1 Cells

Oridonin Induces Apoptosis, Inhibits Migration and Invasion on Highly-Metastatic Human Breast Cancer Cells

Oridonin Induces G2/M Cell Cycle Arrest and Apoptosis Via the PI3K/Akt Signaling Pathway in Hormone-Independent Prostate Cancer Cells.

Oridonin induces autophagy-mediated cell death in pancreatic cancer by activating the c-Jun N-terminal kinase pathway and inhibiting phosphoinositide 3-kinase signaling